Search Results - Ryan Owen

PK/PD modeling to characterize placebo and treatment effect of omalizumab for chronic spontaneous urticaria by Elise Oh, Russ Wada, Kha Le, Yanan Zheng, Jin Jin, Victor Poon, Kit Wong, Ryan Owen, Kenta Yoshida

Connect to this object online.

A mechanistic PK/PD model to enable dose selection of the potent anti‐tryptase antibody (MTPS9579A) in patients with moderate‐to‐severe asthma by Sharon M. Rymut, Lindsay M. Henderson, Victor Poon, Tracy L. Staton, Fang Cai, Siddharth Sukumaran, Horace Rhee, Ryan Owen, Saroja Ramanujan, Kenta Yoshida

Connect to this object online.

Phase I and scintigraphy studies to evaluate safety, tolerability, pharmacokinetics, and lung deposition of inhaled GDC‐0214 in healthy volunteers by Rui Zhu, Hubert Chen, Joshua Galanter, Gaohong She, Fang Cai, Matthew R. Durk, Yixuan Zou, Liuxi Chen, Jane R. Kenny, Shweta Vadhavkar, Simon Warren, Glyn Taylor, Olivia Hwang, Avi Eliahu, Chris Wynne, Ryan Owen

Connect to this object online.

First‐in‐human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC‐2394, in healthy volunteers by Fei Tang, Rebecca Kunder, Tom Chu, Avis Hains, Allen Nguyen, Jacqueline M. McBride, Yu Zhong, Sara Santagostino, Maria Wilson, Abigail Trenchak, Liuxi Chen, Justin Ly, Anita Moein, Nicholas Lewin‐Koh, Vibha Raghavan, Uyi Osaghae, Chris Wynne, Ryan Owen, David Place

Connect to this object online.